QR-060

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameQR-060
Drug Alias NameQR-060
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlomerulosclerosis, Focal SegmentalDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Createrna Science and Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Createrna Science and Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsGlomerulosclerosis, Focal SegmentalDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A